The small SynuClean-D molecule interrupts the formation of the alpha-synuclein amyloid fibres responsible for the onset of Parkinson’s disease, and
Molecule capable of halting and reverting neurodegeneration caused by Parkinson’s disease identified
Home » Parkinson's »
First-of-its-kind Parkinson’s biomarker guidelines invigorates drive for treatments: Creating guidelines for discovering Parkinson’s biomarkers is key to developing treatments
Parkinson’s disease affects more than 4 million people worldwide, with numbers projected to double in the next few decades. With
Contact sports increase Parkinson’s disease risk
At Medical News Today, we have covered studies linking brain injury — usually as a result of playing contact sports
Compound identified that protects against neurodegeneration
Researchers from the University of Liverpool have identified a new compound that protects against neurodegeneration in nematode worms. The discovery
Pathway of Alzheimer’s degeneration discovered: Finding is key for future treatment and earlier diagnosis
Scientists at the Montreal Neurological Institute and Hospital (The Neuro) of McGill University have used a unique approach to track
Powerful new approach helps understand molecular alterations in neurological disease
Neurological diseases are typically associated with a multitude of molecular changes. But out of these thousands of changes in gene
Half of those on Parkinson’s drugs may develop impulse control problems
Over time, half of the people taking certain drugs for Parkinson’s disease may develop impulse control disorders such as compulsive
First photoactive drug to fight Parkinson’s disease
An international team has designed the first potentially therapeutic photoactive drug, MRS7145, to fight Parkinson’s disease, according to the new
Immunosuppressants may reduce Parkinson’s risk
The authors of the study, from Washington University School of Medicine in St. Louis, MO, believe that their results highlight
Study uncovers cause of pesticide exposure, Parkinson’s link
A new University of Guelph study has discovered why exposure to pesticides increases some people’s risk of developing Parkinson’s disease.